Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,628 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 506
Ph III recruiting: 46
Growth YoY: +21.9%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03536182	Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer(CIPHER)	withdrawn	Phase 3	0	University of Texas Southwestern Medical CenterOTHER	2	May 26, 2021	clinicaltrials
NCT04083651	A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer	withdrawn	Phase 2 / Phase 3	0	Bausch Health Americas, Inc.INDUSTRY	1	May 7, 2021